Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ⅲ Clinical Trial to Evaluate the Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine (Human Diploid Cell) in Healthy Adults and Children Aged ≥1 Year

NCT07793227 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.

NCT NCT07793227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07793227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ⅲ Clinical Trial to Evaluate the Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine (Human Diploid Cell) in Healthy Adults and Children Aged ≥1 Year
Lead sponsor
Sinovac Biotech Co., Ltd
Phase
Phase 3
Overall status
Recruiting
Start date
August 20, 2026
Completion date
September 15, 2027
Enrollment
680 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis a vaccine